Within the non-clinical population, there are, however, large individual differences in smooth pursuit performance,
19,20 and twin studies suggest that the accuracy of smooth pursuit is substantially heritable.
21,22 Two early candidate-gene studies were prompted by the dopaminergic theory of schizophrenia. Thus Rybakowski and colleagues
23 reported an association with the Ser-9-Gly polymorphism of the
DRD3 gene, encoding a dopaminergic receptor: The Ser-Ser phenotype was more likely to be accompanied by impaired pursuit, both in healthy controls and in patients with schizophrenia. Similarly, Thaker et al.
24 reported that the Val-158-Met polymorphism of
COMT was associated with differences in predictive pursuit gain in healthy individuals. Another gene of interest—again on account of its being a candidate gene for schizophrenia—has been
NRG1, which encodes neuregulin-1. For a large sample of male military conscripts, Smyrnis and colleagues
25 reported an association between root-mean-square error in smooth pursuit and the single nucleotide polymorphism (SNP) rs6994992 (SNP8NRG243177) in the promoter region of
NRG1. However, negative results for this and other
NRG1 polymorphisms were reported for a Korean population
26 and for an Icelandic population.
27 In a whole-genome study of a mixed cohort of healthy controls and patients with psychotic conditions, Lencer and colleagues
28 found no SNP with genome-wide significance for smooth pursuit gain but reported an association of
IPO8 (chromosome 12p11.21) with initial pursuit acceleration.